Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
72.00    -1.00 (-1.37%)
Bid:
71.00
Ask:
73.00
Spread: 2.00 (2.817%)
Market Cap: £337.35m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Wednesday broker round-up UPDATE

Wed, 04th Jun 2014 09:28
Advanced Computer Software: Panmure Gordon ups target price from 139p to 155p and stays with its buy recommendation.Avacta: Numis shifts target price from 1.9p to 2p and retains a buy recommendation.Balfour Beatty: Westhouse Securities reduces target price from 302p to 220p keeping its neutral rating.Barclays: Espirito Santo cuts target price from 356p to 325p, while its buy recommendation remains unchanged.Britvic: JP Morgan raises target price from 650p to 730p retaining its neutral rating.Cranswick: N+1 Singer ups target price from 1274p to 1291p and leaves its hold recommendation under review.Electrocomponents: Credit Suisse cuts target price from 275p to 260p and downgrades from neutral to underperform.Fenner: UBS cuts target price from 480p to 420p and reiterates its buy recommendation.IMI: Investec moves target price from 1630p to 1640p, while downgrading from buy to hold.Morrison (WM): Deutsche Bank downgrades to sell with a target price of 190p.Poundland Group: JP Morgan lowers target price from 377.4p to 377.15p and upgrades to overweight.Proton Power Systems: Westhouse Securities initiates with a target price of 15p and a buy recommendation.Reed Elsevier: Nomura raises target price from 975p to 1050p and maintains a buy recommendation.RPC Group: Panmure Gordon ups target price from 728p to 787p and keeps a buy recommendation.Staffline: Sanlam Securities initiates with a target price of 1150p and a buy recommendation.

Related News

IN BRIEF: IMI completes first GBP250 million tranche of buyback
8 hours ago

IN BRIEF: IMI completes first GBP250 million tranche of buyback

IMI PLC - Birmingham, England-based engineering firm - Announces that it has completed the first GBP250 million tranche of the share buyback programme...

European shares close higher on US-Iran talks; UK's Starmer resigns
10 hours ago

European shares close higher on US-Iran talks; UK's Starmer resigns

* STOXX 600 up 0.6%, helped by ​banks

UK's FTSE 100 climbs on banks boost; markets ponder PM Starmer's resignation
10 hours ago

UK's FTSE 100 climbs on banks boost; markets ponder PM Starmer's resignation

* easyJet up after Castlelake discloses takeover interest

Avacta Group News

Avacta hails "strong progress" in first half of 2026
16 hours ago

Avacta hails "strong progress" in first half of 2026

(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026.

IN BRIEF: Avacta Group raises GBP9 million for bond repayments
5 Jun 2026

IN BRIEF: Avacta Group raises GBP9 million for bond repayments

Avacta Group PLC - London-based clinical-stage biopharmaceutical company - Raises gross proceeds of approximately GBP9 million from institutional inve...

Avacta to reduce convertible bond debt after £9m placing
5 Jun 2026

Avacta to reduce convertible bond debt after £9m placing

(Sharecast News) - Avacta announced on Friday that it had raised about £9m through an oversubscribed placing with institutional investors and exi...

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value
29 May 2026

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...

Avacta strengthens oncology position in 2025
19 May 2026

Avacta strengthens oncology position in 2025

(Sharecast News) - Avacta Group said on Tuesday that it had strengthened its position as a pure-play oncology biopharmaceutical company during 2025, w...

Avacta Group annual loss widens as cancer treatment trial results loom
19 May 2026

Avacta Group annual loss widens as cancer treatment trial results loom

(Alliance News) - Avacta Group PLC on Tuesday said clinical data from two cancer trials is expected to be released this year as it reported a widened ...

TRADING UPDATES: Vaalco says remainder of 2026 to be "very profitable"
21 Apr 2026

TRADING UPDATES: Vaalco says remainder of 2026 to be "very profitable"

(Alliance News) - The following is a round-up of updates by London-listed companies, issued last Wednesday and not separately reported by Alliance New...